Delving into the Latest Updates on Centaur Pharmaceuticals Pvt Ltd. with Synapse

Overview

Tags

Nervous System Diseases

Endocrinology and Metabolic Disease

Skin and Musculoskeletal Diseases

Synthetic peptide

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Endocrinology and Metabolic Disease	1
Nervous System Diseases	1

Top 5 Drug Type	Count

Synthetic peptide	1

An open-label, balanced, randomized, single-dose, two-treatment, two-sequence, two-period, two-way crossover bioequivalence study of Propiomazine Tablets 25 mg [Test] of Centaur Pharmaceuticals Pvt. Ltd. India with Propavan® 25 mg (Propiomazine Tablets 25 mg) [Reference] of Sanofi-aventis AB, Stockholm, Sweden, in healthy, adult, human Subjects under fasting conditions. - NIL

Start Date02 May 2024

Sponsor / Collaborator

Centaur Pharmaceuticals Pvt Ltd.

CTRI/2023/06/054253 / RecruitingPhase 3

A multicenter, randomized, double-blind, active-control phase III clinical trial of WOXheal® [Diperoxochloric acid] topical solution in the treatment of chronic venous leg ulcer – in comparison with the active-control 0.9% sodium chloride topical solution in addition to standard of care.

Start Date03 Jul 2023

Sponsor / Collaborator

Centaur Pharmaceuticals Pvt Ltd.

100 Clinical Results associated with Centaur Pharmaceuticals Pvt Ltd.

Login to view more data

0 Patents (Medical) associated with Centaur Pharmaceuticals Pvt Ltd.

Login to view more data

12

Literatures (Medical) associated with Centaur Pharmaceuticals Pvt Ltd.

01 Jan 2023·Dissolution Technologies

Dissolution Method Development for Regulatory Approval: A Comprehensive Review and Case Study

Author: Parshuramkar, Pramod ; Kashyap, Pranita ; Khobragade, Deepak

In vitro dissolution testing is an important tool for any oral drug product.It is useful for product development and to ensure the in vivo performance of drug products throughout their com. life without conducting clin. or bioequivalence studies after regulatory approval.It also plays a role in maintaining batch-to-batch consistency, providing quality assurance, supporting biowaiver and post-approval changes, etc.Guidelines from regulatory agencies provide expectations about the dissolution method and acceptance criteria; however, pharmaceutical manufacturers may fail to comply with the requirements or the expectations of the agencies, resulting in dissolution deficiencies.Furthermore, updates in dissolution testing may not be effectively communicated to non-industry scientists who are involved in dissolution or drug delivery research.This article provides a comprehensive review of the current American and European regulatory guidance for solid oral dosage forms followed by a case study to demonstrate how a dissolution method should be developed, which can be used as a framework for any drug product.

01 Apr 2017·World Journal of Pharmaceutical Research

SAFETY AND EFFICACY OF A COMBINATION OF PARACETAMOL, PHENYLEPHRINE AND FEXOFENADINE IN ADULT PATIENTS OF COMMON COLD AND ALLERGIC RHINITIS: PHASE IV STUDY

Author: Pawaskar, Lalit Jeevan ; Kiran, Mayuresh Dilip

Introduction: Common cold and allergic rhinitis both are most commonly encountered diseases in clin. practises in India.Though self-limiting, it accounts for major loss of school and work days.Symptomatic therapy is often used to treat the symptoms.Combination of analgesic/anti-inflammatory/antipyretic, anti-histaminic and nasal decongestant is popular in the treatment of common cold and allergic rhinitis.This Phase IV study evaluated the efficacy and safety of one such combination of Paracetamol, Phenylephrine and Fexofenadine in treatment of common cold and allergic rhinitis.Materials and Methods: Of total 189 enrolled patients, 154 patients completed the study.Efficacy assessment was made by reduction in Total Symptom Score and four point Likert-type scales.Safety assessment was made by analyzing the adverse events through the study.Results: Reduction in mean TSS was done from 6.90 (baseline) to 3.42 (day 3) to 0.88 (day 5).Two points were reduced in Likert-type symptom scale from Severe to Mild in 3 days.Nearly all the patients had >50% reduction in their total symptom score at all visit and majority of patients had complete relief from the symptoms at visit 3.Four episodes of adverse events occurred and all of them were of mild intensity.Conclusion: A combination of Paracetamol, Phenylephrine and Fexofenadine is safe and effective in the treatment of common cold and allergic rhinitis.

European Journal of Biomedical and Pharmaceutical Sciences

Post-marketing surveillance study to evaluate the safety and efficacy of zinc gluconate in paediatric patients of diarrhea

Author: Waghambare, Pramita ; Pawaskar, Lalit ; Sheikh, Shaheen ; Kiran, Mayuresh

Diarrhea is characterised by loose, watery tools, nausea, stomach cramps, pains and other symptoms.Zinc supplementation is considered to be efficacious to minimise the frequency and severity of diarrhea.Zinc has been recommended for the treatment of diarrhea by the WHO and the UNICEF since 2004.If Zinc is paired with oral rehydration solution (ORS) and continued feeding, diarrheal morbidity and mortality can be minimised.This study was conducted to determine the efficacy and safety for Zinc Gluconate equivalent to elemental Zinc 20 mg per 5ml for the treatment of diarrhea in paediatrics in Indian population.A total 180 trial subjects were enrolled for the study.The study was conducted for the duration of 14 days in which the efficacy was analyzed till day 5 as normally the diarrhea gets managed within 5 days and the safety was analyzed till day 14.The improvement in stool consistency and the decrease in average stool frequency were used to determine efficacy.To evaluate safety, the occurrence and severity of the reported adverse events were measured.A 166 trial subjects completed the study.The average stool frequency was 8.73 on day 1 reduced to 4.19 on day 3 and further reduced to 1.89 on day 5.During the study improvement in stool consistency was also observedAdverse events reported by trial subjects were of non-serious and expected nature.Zinc Gluconate was found to be efficacious and safe for the treatment of diarrhea when given along with the ORS.

100 Deals associated with Centaur Pharmaceuticals Pvt Ltd.

Login to view more data

100 Translational Medicine associated with Centaur Pharmaceuticals Pvt Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 18 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Other

Login to view more data